Werewolf Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for HOWL, updated each market day.
HOWL AI Sentiment
AI sees no strong directional signal for Werewolf Therapeutics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Werewolf Therapeutics, Inc. Common Stock
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Sector
Exchange
Market Cap
$43,659,380
Cap Tier
Employees
39
Headquarters
WATERTOWN, MA
Listed Since
April 30, 2021
Website
HOWL Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
HOWL Volatility
Werewolf Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
